![Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma - ScienceDirect Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804917314946-gr1.jpg)
Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma - ScienceDirect
![Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy - Brachytherapy Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy - Brachytherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5400be65-4fc7-425e-b1e8-69f618d25450/gr1_lrg.jpg)
Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy - Brachytherapy
![Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Immunologic relevance - Radiotherapy and Oncology Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Immunologic relevance - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4fe8b63e-8a3e-4138-9f58-c45ed9f64dfc/gr1.jpg)
Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Immunologic relevance - Radiotherapy and Oncology
![Percentage change in tumor burden from baseline to nadir. The percent... | Download Scientific Diagram Percentage change in tumor burden from baseline to nadir. The percent... | Download Scientific Diagram](https://www.researchgate.net/publication/309958605/figure/fig1/AS:601582475423744@1520439847040/Percentage-change-in-tumor-burden-from-baseline-to-nadir-The-percent-change-in-the-sum.png)
Percentage change in tumor burden from baseline to nadir. The percent... | Download Scientific Diagram
![Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas | American Journal of Neuroradiology Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas | American Journal of Neuroradiology](http://www.ajnr.org/content/ajnr/37/9/1581/F1.large.jpg)
Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas | American Journal of Neuroradiology
![Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-97564-1/MediaObjects/41598_2021_97564_Fig1_HTML.png)
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports
![Remote Sensing | Free Full-Text | Performance Analysis of Ocean Surface Topography Altimetry by Ku-Band Near-Nadir Interferometric SAR Remote Sensing | Free Full-Text | Performance Analysis of Ocean Surface Topography Altimetry by Ku-Band Near-Nadir Interferometric SAR](https://www.mdpi.com/remotesensing/remotesensing-09-00933/article_deploy/html/images/remotesensing-09-00933-g001.png)
Remote Sensing | Free Full-Text | Performance Analysis of Ocean Surface Topography Altimetry by Ku-Band Near-Nadir Interferometric SAR
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)† - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)† -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62c48a5d-25fd-44fc-a85f-0399a1a303e3/gr1_lrg.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)† -
![The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP) - ScienceDirect The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405630817300599-gr3.jpg)
The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP) - ScienceDirect
![Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | JCO Precision Oncology Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2021/po.2021.5/po.21.00172/20211008/images/large/po.21.00172t2.jpeg)
Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | JCO Precision Oncology
![Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | JCO Precision Oncology Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2021/po.2021.5/po.21.00172/20211008/images/large/po.21.00172t1.jpeg)
Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | JCO Precision Oncology
![Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality - Urology Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality - Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2001980807/2006902217/gr1.jpg)